Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-26 @ 12:41 AM
Study NCT ID:
NCT01509560
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2012-01-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood
Sponsor:
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-03
First Submit QC Date:
None
Study First Post Date:
2012-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-20
Last Update Post Date:
2017-02-23
Last Update Post Date Type:
ACTUAL